Procter & Gamble Accrued Expenses decreased by 2.7% to $10.46B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.9%, from $9.88B to $10.46B. Over 4 years (FY 2021 to FY 2025), Accrued Expenses shows relatively stable performance with a 1.8% CAGR.
A steady balance is normal, but a rapid increase could indicate rising operational costs or delays in vendor invoicing.
This represents liabilities for expenses that have been incurred but not yet invoiced or paid, such as utilities, profes...
Standard current liability found in almost all corporate balance sheets.
accrued_expenses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.52B | $10.38B | $10.54B | $10.32B | $9.55B | $10.06B | $10.29B | $10.52B | $10.93B | $10.91B | $11.10B | $10.92B | $11.07B | $10.66B | $9.88B | $9.85B | $11.32B | $10.76B | $10.46B |
| QoQ Change | — | -1.4% | +1.6% | -2.1% | -7.5% | +5.3% | +2.4% | +2.2% | +3.9% | -0.2% | +1.7% | -1.6% | +1.4% | -3.7% | -7.3% | -0.3% | +14.9% | -5.0% | -2.7% |
| YoY Change | — | — | — | — | -9.2% | -3.1% | -2.4% | +1.9% | +14.4% | +8.5% | +7.8% | +3.8% | +1.3% | -2.3% | -11.0% | -9.8% | +2.2% | +0.9% | +5.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.